Short Course 2: A Primer on Digital Biomarkers and Measurement in the Connected Era

This event is now offered in a new entirely virtual format.

Overview

As a direct and sole result of the outbreak of the coronavirus disease (COVID-19) and due to circumstances beyond our control, DIA announced that it has decided to change the format of the upcoming Digitial Technology in Clinical Trials meeting from “face-to-face” (in-person) to entirely virtual.

For more information, please review the list of Frequently Asked Questions.

Short Course requires Pre-Registration and is an additional fee.

Technology is changing how we practice medicine. Despite rapid advances, healthcare lags behind other industries in truly putting these technologies to use. A major barrier is the cross-disciplinary approaches required to successfully create and implement these digital products.

Learning objectives

The aim of the course is to provide a common framework of language and clarify core concepts to promote collaboration amongst stakeholders. We will accomplish this through the following course objectives:

Discuss the concept of digital medicine and the types of products available to measure and intervene in human health
Examine the regulatory, ethical, legal and security considerations when adopting digital products in research and clinical care
Define terms that categorize types of digital measurements including biomarker, ePRO, verification and validation

Have an account?

Short Course 2: A Primer on Digital Biomarkers and Measurement in the Connected Era

Overview

Learning objectives

Be informed and stay engaged.